logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Michael Untch

helios klinikum berlin-buch

108H-index
1.4KPaper Count
7.2WCitation Count
Published Papers 315
Publication Date
logo
Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial
errESMO Open
IF8.3
err2026-05-09
err0
errOAAI
errP. Filis; X. Liu; A. Matikas; M. Untch; G.G. Steger; H. Johansson; M. Hellström; M. Gnant; S. Loibl; Y. Brandberg; J. Bergh; T. Foukakis
errShare
errSave
Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errAmadeo M. Parissenti; Sanaa Noubir; Laura B. Pritzker; Thomas Kovala; Carita Lannér; Jennifer Lemon; Tunde Onayemi; Sreepriya Pk; Gabriel Thériault; Maureen E. Trudeau; Michael M. Untch
errShare
errSave
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials
errThe Lancet Oncology
IF0
err2025-11-24
err0
PREAI
errFabio Conforti; Johannes Holtschmidt; Valentina Nekljudova; Isabella Sala; Eleonora Pagan; Christine Solbach; Michael Untch; Carsten Denkert; Vincenzo Bagnardi; Laura Pala; Peter A Fasching; Andreas Schneeweiss; Hans-Joachim Lück; Giuseppe Viale; Tommaso De Pas; Marion van Mackelenbergh; Jens Huober; Volkmar Müller; Theresa Link; Thomas Karn
errShare
errSave
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆
errESMO Open
IF8.3
err2025-10-17
err0
errOAAI
errJ. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi
errShare
errSave
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study
errThe Lancet Regional Health - Europe
IF0
err2025-09-29
err0
errOAAI
errXingrong Liu; Behnaz Binicy; Balazs Acs; Louise Eriksson Bergman; Sibylle Loibl; Michael Gnant; Michael Untch; Antonios Valachis; Jonas Bergh; Johan Hartman; Theodoros Foukakis; Alexios Matikas
errShare
errSave
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025
errEuropean Journal of Surgical Oncology
IF2.9
err2025-09-17
err0
PREAI
errToralf Reimer; Thorsten Kuehn; Volkmar Mueller; Nina Ditsch; Tanja Fehm; Ute-Susann Albert; Rupert Bartsch; Ingo Bauerfeind; Vesna Bjelic-Radisic; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva Maria Fallenberg; Peter A. Fasching; Michael Friedrich; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Andreas Hartkopf; Joerg Heil; Juliane Hoerner-Rieber; Jens Huober; Wolfgang Janni; Hans-Heinrich Kreipe; David Krug; Sherko Kuemmel; Sibylle Loibl; Diana Lueftner; Michael Patrick Lux; Nicolai Maass; Christoph Mundhenke; Tjoung-Won Park-Simon; Mattea Reinisch; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schuetz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Michael Untch; Marion van Mackelenbergh; Isabell Witzel; Achim Woeckel; Rachel Wuerstlein; Maggie Banys-Paluchowski; Marc Thill
errShare
errSave
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
errEuropean Journal of Cancer
IF7.1
err2025-08-05
err0
errOAAI
errLaura L. Michel; Philipp Ziegler; Philipp Kreis; Andreas D. Hartkopf; Markus Wallwiener; Lothar Häberle; Nelson John; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Diana Lüftner; Volkmar Müller; Erik Belleville; Pauline Wimberger; Hans-Martin Enzinger; Hanna Huebner; Sabrina Uhrig; Carolin C. Hack; Petra Krabisch; Peter A. Fasching; Rachel Wuerstlein; Michael Untch; Nina Ditsch; Alexander Hein; Wolfgang Janni; Florin-Andrei Taran; Michael P. Lux; Diethelm Wallwiener; Sara Y. Brucker; Tanja N. Fehm; Andreas Schneeweiss; Chloë Goossens; Tobias Engler
errShare
errSave
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy☆
errAnnals of Oncology
IF65.4
err2025-03-24
err0
PREAI
errS. Loibl; M. Martin; H. Bonnefoi; M. Untch; S.-B. Kim; H.D. Bear; J.A. García-Sáenz; M. Melé Olivé; N. Mc Carthy; K. Gelmon; C.M. Kelly; S.-A. Im; T. Reimer; M. Martinez-Janez; Z. Zhang; M. Toi; L. Provencher; H.S. Rugo; M. Gnant; A. Makris; F. Marmé
errShare
errSave
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2025-02-20
err0
PREAI
errBanys-Paluchowski, Maggie; Hartmann, Steffi; Basali, Timo; Gasparri, Maria Luisa; de Boniface, Jana; Gentilini, Oreste Davide; Cakmak, Gueldeniz Karadeniz; Ditsch, Nina; Stickeler, Elmar; Schlichting, Ellen; Rubio, Isabel; Peintinger, Florentia; Untch, Michael; Mau, Christine; Federspiel, Frederike Klaassen; Bucher, Susanne; Ramaker, Kerstin; Paluchowski, Peter; Bauer, Lelia; Riemer, Sabine; Langanke, Dagmar; Leuf, Tanja Durpektova; Schnabel, Jens; von Abel, Ekkehard; Solbach, Christine; Ovalle, Sonja Caradenas; Hilmer, Kerstin; Bjelic-Radisic, Vesna; Stahl, Nicole; Sanchez-Mendez, Jose I.; Hagen, Vibeke; Hansen, Marit Helene; Krawczyk, Natalia; Sezen, Bilge Aktas; Jursik, Katharina; Thill, Marc; Kolberg, Hans-Christian; Reimer, Toralf; Ruf, Franziska; Wihlfahrt, Kristina; Rief, Angelika; Berger, Tomasz; Schmidt, Esther; Tauber, Nikolas; Froehlich, Sarah; Kuehn, Thorsten
errShare
errSave
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial
errLANCET REGIONAL HEALTH-EUROPE
IF13
err2025-02-01
err1
PREAI
errMatikas, Alexios; Papakonstantinou, Andri; Loibl, Sibylle; Steger, Guenther G.; Untch, Michael; Johansson, Hemming; Hellstrom, Mats; Greil, Richard; Moebus, Volker; Gnant, Michael; Bergh, Jonas
errShare
errSave
Efficacy and safety of ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in older patients (pts) with HR+/HER2-early breast cancer (EBC) in NATALEE
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errUntch, M.; Yardley, D.; Im, S-A.; Pluard, T.; Hart, L.; Crown, J. P.; Freyer, G.; Zamagni, C.; Lopez-Barajas, I. Blancas; Parnizari, F.; Gao, M.; Amin, K.; Hu, H.; Rugo, H. S.
errShare
errSave
Neoadjuvant chemotherapy in inflammatory breast cancer: A meta-analysis of 10 trials of the German Breast Group (GBG)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMichel, L.; Untch, M.; Schneeweiss, A.; Solbach, C.; Blohmer, J-U.; Fasching, P. A.; Wimberger, P.; Hanusch, C.; Rezai, M.; Denkert, C.; Lueck, H-J.; Huober, J.; Schmatloch, S.; Rhiem, K. E.; Just, M.; Link, T.; Ladda, E.; Rey, J.; Holtschmidt, J.; Loibl, S.
errShare
errSave
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
errNPJ BREAST CANCER
IF7.6
err2024-07-13
err0
errOAAI
errFasching, Peter A.; Hu, Chunling; Hart, Steven N.; Ruebner, Matthias; Polley, Eric C.; Gnanaolivu, Rohan D.; Hartkopf, Andreas D.; Huebner, Hanna; Janni, Wolfgang; Hadji, Peyman; Tesch, Hans; Uhrig, Sabrina; Ettl, Johannes; Lux, Michael P.; Lueftner, Diana; Wallwiener, Markus; Wurmthaler, Lena A.; Goossens, Chloe; Mueller, Volkmar; Beckmann, Matthias W.; Hein, Alexander; Anetsberger, Daniel; Belleville, Erik; Wimberger, Pauline; Untch, Michael; Ekici, Arif B.; Kolberg, Hans-Christian; Hartmann, Arndt; Taran, Florin-Andrei; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Haeberle, Lothar; Couch, Fergus J.
errShare
errSave
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2024-06-24
err3
errOAAI
errDent, Rebecca; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Haiderali, Amin; Jia, Liyi; Nguyen, Allison Martin; Pan, Wilbur; O'Shaughnessy, Joyce; Schmid, Peter
errShare
errSave
Palbociclib combined with endocrine treatment in hormone receptorpositive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
errESMO OPEN
IF8.3
err2024-06-01
err1
errOAAI
errMarme, F.; Martin, M.; Untch, M.; Thode, C.; Bonnefoi, H.; Kim, S. b.; Bear, H.; Mc Carthy, N.; Gelmon, K.; Garcia-Saenz, J. A.; Kelly, C. M.; Reimer, T.; Valota, O.; Toi, M.; Rugo, H. S.; Gnant, M.; Makris, A.; Bassy, M.; Zhang, Z.; Furlanetto, J.; Nekljudova, V.; Loibl, S.
errShare
errSave
CDH1 mutations predict resistance to neoadjuvant taxane therapy
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errKnappskog, Stian; Helwa, Reham; Rachakonda, Sivaramakrishna; Gansmo, Liv B.; Denkert, Carsten; Yates, Lucy R.; Solbach, Christine; Untch, Michael; Sinn, Bruno V.; Litmeyer, Anne-Sophie; Ataseven, Beyhan; Huober, Jens; Wedge, David C.; Karn, Thomas; Nikolaienko, Oleksii; Marme, Frederik; Fasching, Peter A.; Eikesdal, Hans Petter; Stickeler, Elmar; Schem, Christian; Jank, Paul; van Mackelenbergh, Marion; Muller, Volkmar; Felder, Baerbel; Holtschmidt, Johannes; Campbell, Peter J.; Loibl, Sibylle; Lonning, Per
errShare
errSave
Ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2-early breast cancer: final invasive disease-free survival (iDFS) analysis from the NATALEE trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err3
PREAI
errHortobagyi, Gabriel; Stroyakovsky, Daniil; Yardley, Denise; Huang, Chiun-Shen; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Parnizari, Federico; Ghaznawi, Farhat; Li, Zheng; Waters, Sorcha; Chakravartty, Arunava; Slamon, Dennis
errShare
errSave
SerMa (Seroma of the Mammary gland) pilot - Is there a possible link between macrophage-based immune response and age?
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errKoepke, Melitta; Schneider, Felicitas; Kuhn, Christina; Wild, Mathis; Schneider, Mariella; Pochert, Nicole; Traidl-Hoffmann, Claudia; Sagasser, Jacqueline; Dannecker, Christian; Hinske, Christian; Banys-Paluchowski, Maggie; Untch, Michael; Kuhn, Thorsten; Jeschke, Udo; Ditsch, Nina
errShare
errSave
Germline mutation status of BRCA1/2 and other breast cancer predisposition genes as predictive and prognostic biomarker: Results of the GeparX study (GeparX-BRCA)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errSchmutzler, Rita K.; Link, Theresa; Hahnen, Eric; Reinisch, Mattea; Hauke, Jan; Just, Marianne; Untch, Michael; Ernst, Corinna; Stotzer, Oliver; Fasching, Peter A.; Kayali, Mohamad; Wimberger, Pauline; Schneeweiss, Andreas; Schmidt, Sandra; Seiler, Sabine; Jackisch, Christian; Thill, Marc; Rhiem, Kerstin; Denkert, Carsten; Nekljudova, Valentina; Holtschmidt, Johannes; Blohmer, Jens-Uwe; Loibl, Sibylle
errShare
errSave
Phase III study of adjuvant ado-trastuzumab emtansine vs trastuzumab for residual invasive HER2-positive early breast cancer after neoadjuvant chemotherapy and HER2-targeted therapy: KATHERINE final IDFS and updated OS analysis
errCANCER RESEARCH
IF16.6
err2024-05-02
err8
PREAI
errLoibl, Sibylle; Mano, Max; Untch, Michael; Huang, Chiun-Shen; Mamounas, Eleftherios; Wolmark, Norman; Knott, Adam; Siddiqui, Asna; Boulet, Thomas; Nyawira, Beatrice; Restuccia, Eleonora; Geyer, Charles
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
JoAnn E. Manson
H-index: 255 · Papers: 2.7K
H
Hermann Brenner
H-index: 202 · Papers: 3.3K
C
Charles M. Perou
H-index: 193 · Papers: 2.0K
B
Børge G. Nordestgaard
H-index: 192 · Papers: 1.8K
G
Gabriel N. Hortobágyi
H-index: 187 · Papers: 1.9K
View more